Among a total of 200 patients, we identified a cohort of 72 patients with lung adenocarcinoma (LUAD) who were treated with pemetrexed plus carboplatin and had tumor RNA expression data on both the MTAP and CDKN2A genes (Fig. 4a). The gene discussed is CDKN2A; the disease is lung adenocarcinoma.